GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $8,367,000 | +32.2% | 72,500 | +11.5% | 2.49% | +28.6% |
Q3 2020 | $6,328,000 | -31.2% | 65,000 | -13.3% | 1.94% | -29.8% |
Q2 2020 | $9,204,000 | +40.1% | 75,000 | 0.0% | 2.76% | -4.7% |
Q1 2020 | $6,568,000 | +214.1% | 75,000 | +275.0% | 2.89% | +255.4% |
Q4 2019 | $2,091,000 | – | 20,000 | – | 0.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |